{"description":"Documents published on or after 10/13/2026 and from Drug Enforcement Administration","count":22,"total_pages":2,"next_page_url":"https://www.federalregister.gov/api/v1/documents?conditions%5Bagencies%5D%5B%5D=drug-enforcement-administration&conditions%5Bpublication_date%5D%5Bgte%5D=2026-10-13&format=json&page=2&search_after_cursor=WzE3OTE5MzYwMDAwMDAsIjIwMjYtMjA5NDMiXQ","results":[{"title":"Schedules of Controlled Substances: Placement of Centanafadine in Schedule III","type":"Rule","abstract":"On July 24, 2026, the United States Food and Drug Administration (FDA) approved a new drug application for Simtriyo (centanafadine) for the treatment of attention-deficit/hyperactivity disorder in adults and pediatric patients aged 6 years and older, weighing at least 20 kg. The Department of Health and Human Services provided the Drug Enforcement Administration (DEA) with a scheduling recommendation to place centanafadine, chemically known as (1R,5S)-1- (naphthalen-2-yl)-3-azabicyclo[3.1.0]hexane, in schedule III of the Controlled Substances Act (CSA). In accordance with the CSA, as amended by the Improving Regulatory Transparency for New Medical Therapies Act, DEA is hereby issuing an interim final rule placing centanafadine, including its salts, isomers (whether optical, positional, or geometric), and salts of such isomers whenever the existence of such salts, isomers, and salts of isomers is possible in schedule III of the CSA.","document_number":"2026-22208","html_url":"https://www.federalregister.gov/documents/2026/10/30/2026-22208/schedules-of-controlled-substances-placement-of-centanafadine-in-schedule-iii","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2026-10-30/pdf/2026-22208.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2026-22208.pdf?1793277918","publication_date":"2026-10-30","agencies":[{"raw_name":"DEPARTMENT OF JUSTICE","name":"Justice Department","id":268,"url":"https://www.federalregister.gov/agencies/justice-department","json_url":"https://www.federalregister.gov/api/v1/agencies/268","parent_id":null,"slug":"justice-department"},{"raw_name":"Drug Enforcement Administration","name":"Drug Enforcement Administration","id":116,"url":"https://www.federalregister.gov/agencies/drug-enforcement-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/116","parent_id":268,"slug":"drug-enforcement-administration"}],"excerpts":"On July 24, 2026, the United States Food and Drug Administration (FDA) approved a new drug application for Simtriyo (centanafadine) for the treatment of attention-deficit/hyperactivity disorder in adults and pediatric patients aged 6 years and older,..."},{"title":"Bulk Manufacturer of Controlled Substances Application: Sigma Aldrich Research Biochemicals, Inc.","type":"Notice","abstract":"Sigma Aldrich Research Biochemicals, Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.","document_number":"2026-22048","html_url":"https://www.federalregister.gov/documents/2026/10/29/2026-22048/bulk-manufacturer-of-controlled-substances-application-sigma-aldrich-research-biochemicals-inc","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2026-10-29/pdf/2026-22048.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2026-22048.pdf?1793191513","publication_date":"2026-10-29","agencies":[{"raw_name":"DEPARTMENT OF JUSTICE","name":"Justice Department","id":268,"url":"https://www.federalregister.gov/agencies/justice-department","json_url":"https://www.federalregister.gov/api/v1/agencies/268","parent_id":null,"slug":"justice-department"},{"raw_name":"Drug Enforcement Administration","name":"Drug Enforcement Administration","id":116,"url":"https://www.federalregister.gov/agencies/drug-enforcement-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/116","parent_id":268,"slug":"drug-enforcement-administration"}],"excerpts":"Sigma Aldrich Research Biochemicals, Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information."},{"title":"Vida Janson, M.D.; Decision and Order","type":"Notice","abstract":null,"document_number":"2026-21799","html_url":"https://www.federalregister.gov/documents/2026/10/26/2026-21799/vida-janson-md-decision-and-order","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2026-10-26/pdf/2026-21799.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2026-21799.pdf?1792759518","publication_date":"2026-10-26","agencies":[{"raw_name":"DEPARTMENT OF JUSTICE","name":"Justice Department","id":268,"url":"https://www.federalregister.gov/agencies/justice-department","json_url":"https://www.federalregister.gov/api/v1/agencies/268","parent_id":null,"slug":"justice-department"},{"raw_name":"Drug Enforcement Administration","name":"Drug Enforcement Administration","id":116,"url":"https://www.federalregister.gov/agencies/drug-enforcement-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/116","parent_id":268,"slug":"drug-enforcement-administration"}],"excerpts":null},{"title":"Barry Backiewicz, D.D.S.; Decision and Order","type":"Notice","abstract":null,"document_number":"2026-21725","html_url":"https://www.federalregister.gov/documents/2026/10/26/2026-21725/barry-backiewicz-dds-decision-and-order","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2026-10-26/pdf/2026-21725.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2026-21725.pdf?1792759510","publication_date":"2026-10-26","agencies":[{"raw_name":"DEPARTMENT OF JUSTICE","name":"Justice Department","id":268,"url":"https://www.federalregister.gov/agencies/justice-department","json_url":"https://www.federalregister.gov/api/v1/agencies/268","parent_id":null,"slug":"justice-department"},{"raw_name":"Drug Enforcement Administration","name":"Drug Enforcement Administration","id":116,"url":"https://www.federalregister.gov/agencies/drug-enforcement-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/116","parent_id":268,"slug":"drug-enforcement-administration"}],"excerpts":null},{"title":"Peter Michael Wills, D.D.S.; Decision and Order","type":"Notice","abstract":null,"document_number":"2026-21415","html_url":"https://www.federalregister.gov/documents/2026/10/20/2026-21415/peter-michael-wills-dds-decision-and-order","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2026-10-20/pdf/2026-21415.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2026-21415.pdf?1792413912","publication_date":"2026-10-20","agencies":[{"raw_name":"DEPARTMENT OF JUSTICE","name":"Justice Department","id":268,"url":"https://www.federalregister.gov/agencies/justice-department","json_url":"https://www.federalregister.gov/api/v1/agencies/268","parent_id":null,"slug":"justice-department"},{"raw_name":"Drug Enforcement Administration","name":"Drug Enforcement Administration","id":116,"url":"https://www.federalregister.gov/agencies/drug-enforcement-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/116","parent_id":268,"slug":"drug-enforcement-administration"}],"excerpts":null},{"title":"Jan Pijanowski, M.D.; Decision and Order","type":"Notice","abstract":null,"document_number":"2026-21414","html_url":"https://www.federalregister.gov/documents/2026/10/20/2026-21414/jan-pijanowski-md-decision-and-order","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2026-10-20/pdf/2026-21414.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2026-21414.pdf?1792413912","publication_date":"2026-10-20","agencies":[{"raw_name":"DEPARTMENT OF JUSTICE","name":"Justice Department","id":268,"url":"https://www.federalregister.gov/agencies/justice-department","json_url":"https://www.federalregister.gov/api/v1/agencies/268","parent_id":null,"slug":"justice-department"},{"raw_name":"Drug Enforcement Administration","name":"Drug Enforcement Administration","id":116,"url":"https://www.federalregister.gov/agencies/drug-enforcement-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/116","parent_id":268,"slug":"drug-enforcement-administration"}],"excerpts":null},{"title":"Jefferson Burroughs, M.D.; Decision and Order","type":"Notice","abstract":null,"document_number":"2026-21413","html_url":"https://www.federalregister.gov/documents/2026/10/20/2026-21413/jefferson-burroughs-md-decision-and-order","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2026-10-20/pdf/2026-21413.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2026-21413.pdf?1792413912","publication_date":"2026-10-20","agencies":[{"raw_name":"DEPARTMENT OF JUSTICE","name":"Justice Department","id":268,"url":"https://www.federalregister.gov/agencies/justice-department","json_url":"https://www.federalregister.gov/api/v1/agencies/268","parent_id":null,"slug":"justice-department"},{"raw_name":"Drug Enforcement Administration","name":"Drug Enforcement Administration","id":116,"url":"https://www.federalregister.gov/agencies/drug-enforcement-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/116","parent_id":268,"slug":"drug-enforcement-administration"}],"excerpts":null},{"title":"Youmna Abdulhadi, M.D.; Decision and Order","type":"Notice","abstract":null,"document_number":"2026-21410","html_url":"https://www.federalregister.gov/documents/2026/10/20/2026-21410/youmna-abdulhadi-md-decision-and-order","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2026-10-20/pdf/2026-21410.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2026-21410.pdf?1792413912","publication_date":"2026-10-20","agencies":[{"raw_name":"DEPARTMENT OF JUSTICE","name":"Justice Department","id":268,"url":"https://www.federalregister.gov/agencies/justice-department","json_url":"https://www.federalregister.gov/api/v1/agencies/268","parent_id":null,"slug":"justice-department"},{"raw_name":"Drug Enforcement Administration","name":"Drug Enforcement Administration","id":116,"url":"https://www.federalregister.gov/agencies/drug-enforcement-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/116","parent_id":268,"slug":"drug-enforcement-administration"}],"excerpts":null},{"title":"Importer of Controlled Substances Application: Organic Standards Solutions International, LLC","type":"Notice","abstract":"Organic Standards Solutions International, LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.","document_number":"2026-21370","html_url":"https://www.federalregister.gov/documents/2026/10/19/2026-21370/importer-of-controlled-substances-application-organic-standards-solutions-international-llc","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2026-10-19/pdf/2026-21370.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2026-21370.pdf?1792154726","publication_date":"2026-10-19","agencies":[{"raw_name":"DEPARTMENT OF JUSTICE","name":"Justice Department","id":268,"url":"https://www.federalregister.gov/agencies/justice-department","json_url":"https://www.federalregister.gov/api/v1/agencies/268","parent_id":null,"slug":"justice-department"},{"raw_name":"Drug Enforcement Administration","name":"Drug Enforcement Administration","id":116,"url":"https://www.federalregister.gov/agencies/drug-enforcement-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/116","parent_id":268,"slug":"drug-enforcement-administration"}],"excerpts":"Organic Standards Solutions International, LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information."},{"title":"Bulk Manufacturer of Controlled Substances Application: Janssen Pharmaceuticals, Inc.","type":"Notice","abstract":"Janssen Pharmaceuticals, Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.","document_number":"2026-21369","html_url":"https://www.federalregister.gov/documents/2026/10/19/2026-21369/bulk-manufacturer-of-controlled-substances-application-janssen-pharmaceuticals-inc","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2026-10-19/pdf/2026-21369.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2026-21369.pdf?1792154726","publication_date":"2026-10-19","agencies":[{"raw_name":"DEPARTMENT OF JUSTICE","name":"Justice Department","id":268,"url":"https://www.federalregister.gov/agencies/justice-department","json_url":"https://www.federalregister.gov/api/v1/agencies/268","parent_id":null,"slug":"justice-department"},{"raw_name":"Drug Enforcement Administration","name":"Drug Enforcement Administration","id":116,"url":"https://www.federalregister.gov/agencies/drug-enforcement-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/116","parent_id":268,"slug":"drug-enforcement-administration"}],"excerpts":"Janssen Pharmaceuticals, Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information."},{"title":"Bulk Manufacturer of Controlled Substances Application: Groff Health Inc","type":"Notice","abstract":"Groff Health Inc has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.","document_number":"2026-21368","html_url":"https://www.federalregister.gov/documents/2026/10/19/2026-21368/bulk-manufacturer-of-controlled-substances-application-groff-health-inc","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2026-10-19/pdf/2026-21368.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2026-21368.pdf?1792154726","publication_date":"2026-10-19","agencies":[{"raw_name":"DEPARTMENT OF JUSTICE","name":"Justice Department","id":268,"url":"https://www.federalregister.gov/agencies/justice-department","json_url":"https://www.federalregister.gov/api/v1/agencies/268","parent_id":null,"slug":"justice-department"},{"raw_name":"Drug Enforcement Administration","name":"Drug Enforcement Administration","id":116,"url":"https://www.federalregister.gov/agencies/drug-enforcement-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/116","parent_id":268,"slug":"drug-enforcement-administration"}],"excerpts":"Groff Health Inc has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information."},{"title":"Importer of Controlled Substances Application: Groff NA Hemplex LLC","type":"Notice","abstract":"Groff NA Hemplex LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.","document_number":"2026-21367","html_url":"https://www.federalregister.gov/documents/2026/10/19/2026-21367/importer-of-controlled-substances-application-groff-na-hemplex-llc","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2026-10-19/pdf/2026-21367.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2026-21367.pdf?1792154726","publication_date":"2026-10-19","agencies":[{"raw_name":"DEPARTMENT OF JUSTICE","name":"Justice Department","id":268,"url":"https://www.federalregister.gov/agencies/justice-department","json_url":"https://www.federalregister.gov/api/v1/agencies/268","parent_id":null,"slug":"justice-department"},{"raw_name":"Drug Enforcement Administration","name":"Drug Enforcement Administration","id":116,"url":"https://www.federalregister.gov/agencies/drug-enforcement-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/116","parent_id":268,"slug":"drug-enforcement-administration"}],"excerpts":"Groff NA Hemplex LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information."},{"title":"Bulk Manufacturer of Controlled Substances Application: Scottsdale Research Institute","type":"Notice","abstract":"Scottsdale Research Institute has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.","document_number":"2026-21360","html_url":"https://www.federalregister.gov/documents/2026/10/19/2026-21360/bulk-manufacturer-of-controlled-substances-application-scottsdale-research-institute","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2026-10-19/pdf/2026-21360.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2026-21360.pdf?1792154725","publication_date":"2026-10-19","agencies":[{"raw_name":"DEPARTMENT OF JUSTICE","name":"Justice Department","id":268,"url":"https://www.federalregister.gov/agencies/justice-department","json_url":"https://www.federalregister.gov/api/v1/agencies/268","parent_id":null,"slug":"justice-department"},{"raw_name":"Drug Enforcement Administration","name":"Drug Enforcement Administration","id":116,"url":"https://www.federalregister.gov/agencies/drug-enforcement-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/116","parent_id":268,"slug":"drug-enforcement-administration"}],"excerpts":"Scottsdale Research Institute has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information."},{"title":"Bulk Manufacturer of Controlled Substances Application: National Center for Natural Products Research University of Mississippi/NCNPR","type":"Notice","abstract":"National Center for Natural Products Research University of Mississippi/NCNPR has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.","document_number":"2026-21359","html_url":"https://www.federalregister.gov/documents/2026/10/19/2026-21359/bulk-manufacturer-of-controlled-substances-application-national-center-for-natural-products-research","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2026-10-19/pdf/2026-21359.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2026-21359.pdf?1792154725","publication_date":"2026-10-19","agencies":[{"raw_name":"DEPARTMENT OF JUSTICE","name":"Justice Department","id":268,"url":"https://www.federalregister.gov/agencies/justice-department","json_url":"https://www.federalregister.gov/api/v1/agencies/268","parent_id":null,"slug":"justice-department"},{"raw_name":"Drug Enforcement Administration","name":"Drug Enforcement Administration","id":116,"url":"https://www.federalregister.gov/agencies/drug-enforcement-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/116","parent_id":268,"slug":"drug-enforcement-administration"}],"excerpts":"National Center for Natural Products Research University of Mississippi/NCNPR has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information."},{"title":"Importer of Controlled Substances Application: National Center for Natural Products Research","type":"Notice","abstract":"National Center for Natural Products Research has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.","document_number":"2026-21358","html_url":"https://www.federalregister.gov/documents/2026/10/19/2026-21358/importer-of-controlled-substances-application-national-center-for-natural-products-research","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2026-10-19/pdf/2026-21358.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2026-21358.pdf?1792154725","publication_date":"2026-10-19","agencies":[{"raw_name":"DEPARTMENT OF JUSTICE","name":"Justice Department","id":268,"url":"https://www.federalregister.gov/agencies/justice-department","json_url":"https://www.federalregister.gov/api/v1/agencies/268","parent_id":null,"slug":"justice-department"},{"raw_name":"Drug Enforcement Administration","name":"Drug Enforcement Administration","id":116,"url":"https://www.federalregister.gov/agencies/drug-enforcement-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/116","parent_id":268,"slug":"drug-enforcement-administration"}],"excerpts":"National Center for Natural Products Research has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information."},{"title":"Importer of Controlled Substances Application: Groff Health Inc.","type":"Notice","abstract":"Groff Health Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.","document_number":"2026-21355","html_url":"https://www.federalregister.gov/documents/2026/10/19/2026-21355/importer-of-controlled-substances-application-groff-health-inc","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2026-10-19/pdf/2026-21355.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2026-21355.pdf?1792154724","publication_date":"2026-10-19","agencies":[{"raw_name":"DEPARTMENT OF JUSTICE","name":"Justice Department","id":268,"url":"https://www.federalregister.gov/agencies/justice-department","json_url":"https://www.federalregister.gov/api/v1/agencies/268","parent_id":null,"slug":"justice-department"},{"raw_name":"Drug Enforcement Administration","name":"Drug Enforcement Administration","id":116,"url":"https://www.federalregister.gov/agencies/drug-enforcement-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/116","parent_id":268,"slug":"drug-enforcement-administration"}],"excerpts":"Groff Health Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information."},{"title":"Importer of Controlled Substances Application: DMS Pharmaceutical Group","type":"Notice","abstract":"DMS Pharmaceutical Group has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.","document_number":"2026-21354","html_url":"https://www.federalregister.gov/documents/2026/10/19/2026-21354/importer-of-controlled-substances-application-dms-pharmaceutical-group","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2026-10-19/pdf/2026-21354.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2026-21354.pdf?1792154724","publication_date":"2026-10-19","agencies":[{"raw_name":"DEPARTMENT OF JUSTICE","name":"Justice Department","id":268,"url":"https://www.federalregister.gov/agencies/justice-department","json_url":"https://www.federalregister.gov/api/v1/agencies/268","parent_id":null,"slug":"justice-department"},{"raw_name":"Drug Enforcement Administration","name":"Drug Enforcement Administration","id":116,"url":"https://www.federalregister.gov/agencies/drug-enforcement-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/116","parent_id":268,"slug":"drug-enforcement-administration"}],"excerpts":"DMS Pharmaceutical Group has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information."},{"title":"Importer of Controlled Substances Application: Halo Pharmaceutical Inc.","type":"Notice","abstract":"Halo Pharmaceutical Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.","document_number":"2026-21353","html_url":"https://www.federalregister.gov/documents/2026/10/19/2026-21353/importer-of-controlled-substances-application-halo-pharmaceutical-inc","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2026-10-19/pdf/2026-21353.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2026-21353.pdf?1792154724","publication_date":"2026-10-19","agencies":[{"raw_name":"DEPARTMENT OF JUSTICE","name":"Justice Department","id":268,"url":"https://www.federalregister.gov/agencies/justice-department","json_url":"https://www.federalregister.gov/api/v1/agencies/268","parent_id":null,"slug":"justice-department"},{"raw_name":"Drug Enforcement Administration","name":"Drug Enforcement Administration","id":116,"url":"https://www.federalregister.gov/agencies/drug-enforcement-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/116","parent_id":268,"slug":"drug-enforcement-administration"}],"excerpts":"Halo Pharmaceutical Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information."},{"title":"Muhamad Aly Rifai, M.D.; Decision and Order","type":"Notice","abstract":null,"document_number":"2026-21258","html_url":"https://www.federalregister.gov/documents/2026/10/19/2026-21258/muhamad-aly-rifai-md-decision-and-order","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2026-10-19/pdf/2026-21258.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2026-21258.pdf?1792154712","publication_date":"2026-10-19","agencies":[{"raw_name":"DEPARTMENT OF JUSTICE","name":"Justice Department","id":268,"url":"https://www.federalregister.gov/agencies/justice-department","json_url":"https://www.federalregister.gov/api/v1/agencies/268","parent_id":null,"slug":"justice-department"},{"raw_name":"Drug Enforcement Administration","name":"Drug Enforcement Administration","id":116,"url":"https://www.federalregister.gov/agencies/drug-enforcement-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/116","parent_id":268,"slug":"drug-enforcement-administration"}],"excerpts":null},{"title":"Schedules of Controlled Substances: Temporary Placement of 7- Hydroxymitragynine and Mitragynine Pseudoindoxyl Above a Specified Threshold in Schedule I","type":"Proposed Rule","abstract":"The Administrator of the Drug Enforcement Administration (DEA) is issuing this notice of intent to publish a temporary order to schedule 7-hydroxymitragynine and mitragynine pseudoindoxyl (including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, whenever the existence of such isomers, esters, ethers, and salts is possible) when either substance alone, or their combined amount if both are present, is above a specified threshold, in schedule I of the Controlled Substances Act (CSA). Based on a different threshold provided by the Department of Health and Human Services (HHS) in July of 2025, DEA published a notice of intent to temporarily schedule 7-hydroxymitragynine above that lower threshold on July 7, 2026. Additionally, DEA published a temporary order placing mitragynine pseudoindoxyl without a threshold in schedule I of the CSA on August 26, 2026. On October 8, 2026, HHS sent a letter recommending that DEA place of the CSA 7-hydroxymitragynine and mitragynine pseudoindoxyl in schedule I when either substance alone, or their combined amount if both are present, is above a new specified threshold. Based on the October 8, 2026 letter, DEA is issuing this notice of intent. While the new threshold recommended by HHS would permit certain products to remain in the marketplace without being subject to schedule I controls, neither HHS nor DEA has made a finding that these substances are safe to use at below-threshold levels. When a temporary order is issued, it will impose the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, reverse distribute, import, export, engage in research, conduct instructional activities or chemical analysis with, or possess) or propose to handle 7- hydroxymitragynine and/or mitragynine pseudoindoxyl above the specified threshold. In a separate document contained in this issue of the Federal Register, DEA is withdrawing the July 7, 2026 notice of intent related to 7-hydroxymitragynine. The August 26, 2026 temporary order placing mitragynine pseudoindoxyl in schedule I of the CSA without a threshold remains in effect until either it expires or the new temporary order is published and the previous order is withdrawn, whichever occurs first.","document_number":"2026-20943","html_url":"https://www.federalregister.gov/documents/2026/10/14/2026-20943/schedules-of-controlled-substances-temporary-placement-of-7--hydroxymitragynine-and-mitragynine","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2026-10-14/pdf/2026-20943.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2026-20943.pdf?1791561615","publication_date":"2026-10-14","agencies":[{"raw_name":"DEPARTMENT OF JUSTICE","name":"Justice Department","id":268,"url":"https://www.federalregister.gov/agencies/justice-department","json_url":"https://www.federalregister.gov/api/v1/agencies/268","parent_id":null,"slug":"justice-department"},{"raw_name":"Drug Enforcement Administration","name":"Drug Enforcement Administration","id":116,"url":"https://www.federalregister.gov/agencies/drug-enforcement-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/116","parent_id":268,"slug":"drug-enforcement-administration"}],"excerpts":"The Administrator of the Drug Enforcement Administration (DEA) is issuing this notice of intent to publish a temporary order to schedule 7-hydroxymitragynine and mitragynine pseudoindoxyl (including their isomers, esters, ethers, salts, and salts of..."}]}